Trinity Biotech Plc (TRIB) Tops Q1 EPS by 0c

Go back to Trinity Biotech Plc (TRIB) Tops Q1 EPS by 0c

Trinity Biotech Announces Quarter 1 Results -- EPS 17.4 Cents Dividend of 22 Cents

April 30, 2015 8:23 AM EDT

DUBLIN, Ireland, April 30, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2015.

Quarter 1 Results

Total revenues for Q1, 2015 were $25.2m, an increase of $0.2m when compared with Q1, 2014. However, revenues this quarter were particularly impacted by foreign exchange movements due to the strengthening of the US dollar against a range of currencies. Excluding this currency effect, revenues would have increased to $26.4m, representing an increase of 6%.

... More

Trinity Biotech Announces Quarter 1 Results -- EPS 17.4 Cents Dividend of 22 Cents

April 30, 2015 8:23 AM EDT

DUBLIN, Ireland, April 30, 2015 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2015.

Quarter 1 Results

Total revenues for Q1, 2015 were $25.2m, an increase of $0.2m when compared with Q1, 2014. However, revenues this quarter were particularly impacted by foreign exchange movements due to the strengthening of the US dollar against a range of currencies. Excluding this currency effect, revenues would have increased to $26.4m, representing an increase of 6%.

... More